Correction: Uncovering potential molecular biomarkers for cancer-associated secondary lymphedema through integrated analyses of RNA-sequencing, machine learning, and clinical data - Summary - MDSpire

Correction: Uncovering potential molecular biomarkers for cancer-associated secondary lymphedema through integrated analyses of RNA-sequencing, machine learning, and clinical data

  • By

  • Hao Dong

  • Jianliang Miao

  • Zhong Liu

  • Yuguang Sun

  • Peilin Li

  • Song Xia

  • Wenbin Shen

  • July 9, 2026

  • 0 min

Share

Objective:

To correct an error in the original publication regarding the GAPDH primer sequence.

Key Findings:
  • The original article contained an error in the GAPDH primer sequence in Table S1.
  • A corrected file has been published.
Interpretation:

The original version of the article has been updated to reflect the correction.

Conclusion:

The correction addresses a specific error in the supplementary data.

Sources:

Original Source(s)

Correction: Uncovering potential molecular biomarkers for cancer-associated secondary lymphedema through integrated analyses of RNA-sequencing, machine learning, and clinical data

  • by Hao Dong, Jianliang Miao, Zhong Liu, Yuguang Sun, Peilin Li, Song Xia, Wenbin Shen

  • July 9, 2026

Related Content

Machine and deep learning based on magnetic resonance imaging to segment glioblastoma and predict the spread of recurrence: a multicenter retrospective protocol

RHOA at the intersection of inflammation-driven and sporadic colorectal cancer

Beyond the dose-volume histogram: a critical appraisal of normal tissue complication probability modelling for osteoradionecrosis of the jaw and a strategic framework for clinical translation